Showing results (381-390 of 407) with videos related to

Sort By:
Pageof 41
Annals of the Rheumatic Diseases|March 6, 2012
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisDanielle M Gerlag, Karim Raza, Lisa G M van Baarsen, et al.
Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
The Journal of Experimental Medicine|July 30, 2008
Autoregulation of Th1-mediated inflammation by twist1Uwe Niesner, Inka Albrecht, Marko Janke, et al.
Talanta|October 22, 2023
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care unitsSabine Kugler, Lisa Hahnefeld, Jan Andreas Kloka, et al.
Annals of the Rheumatic Diseases|August 6, 2026
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trialDésirée van der Heijde, Philip J Mease, Carle Paul, et al.
Biomedicines|October 27, 2022
Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic ArthritisRobert Gurke, Annika Bendes, John Bowes, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Annals of the Rheumatic Diseases|April 30, 2015
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locusJohn Bowes, Sabine Loehr, Ashley Budu-Aggrey, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Arthritis and Rheumatism|September 28, 2010
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Pageof 41